Sino Biopharmaceutical | 1177 - Los Gastos De Explotación

Precio De Mercado
5.54
Cambio Diario
-0.14 -2.46%
Mensual
-5.30%
Anual
44.27%
Q2 Expectativa
5.50




Los Gastos De Explotación Cambio Fecha
Akebia Therapeutics USD 63.08M 8.26M 2025-12
Alaunos Therapeutics USD 1.19M 148K 2025-09
Avita Medical AUD 28.02M 1.55M 2025-12
Cspc Pharmaceutical CNY 5.91B 512.77M 2025-12
Dianthus Therapeutics USD 69.82M 29.14M 2025-12
Ionis Pharmaceuticals USD 418M 101.1M 2025-12
IQVIA Holdings USD 1.69B 4.47B 2025-12
Jiangsu Hengrui CNY 5.52B 604.29M 2026-03
Moderna USD 1.54B 259M 2025-12
Organon & Co USD 906M 362M 2025-09
Revvity USD 626.22M 25.62M 2025-12
Sino Biopharmaceutical CNY 12.39B 1.26B 2025-06
Tectonic Therapeutic USD 21.52M 374K 2025-12
Viatris USD 3.86B 335.7M 2025-12
Xeris Pharmaceuticals USD 69.03M 1.38M 2025-12